Life Sciences Collaborations + Licensing
Recent Highlights
Atalanta Therapeutics Launches With $110 Million To Pioneer RNAi Therapeutics For Neurodegenerative Diseases
Enara Bio and Boehringer Ingelheim Enter Strategic Collaboration and Licensing Agreement to Discover Novel Shared Antigens for Cancer Immunotherapies
Biond Biologics And Sanofi Enter Into Global Licensing Agreement $125 Million Upfront And Over $1 Billion In Milestone And Royalty Payments
Surface Oncology Signs Exclusive License Agreement With GSK, $85 Million Upfront Payment With Additional $730 Million In Milestone Payments Plus Royalties
BridgeBio Forms Joint Venture With Maze Therapeutics To Treat Cardiovascular Disease
Relay Therapeutics Announces Collaboration and License Agreement with Genentech for RLY-1971
Schrödinger Announces $2.7 Billion Collaboration With Bristol Myers Squibb
Lacerta Therapeutics Enters R&D Collaboration with UCB
News
Cullinan Management Enters Strategic Partnership with Zai Lab for $20 Million Upfront and up to $211 Million in Milestone Payments
View More
Atalanta Therapeutics Launches With $110 Million To Pioneer RNAi Therapeutics For Neurodegenerative Diseases
View More
Enara Bio and Boehringer Ingelheim Enter Strategic Collaboration and Licensing Agreement to Discover Novel Shared Antigens for Cancer Immunotherapies
View More
Biond Biologics And Sanofi Enter Into Global Licensing Agreement $125 Million Upfront And Over $1 Billion In Milestone And Royalty Payments
View More
A
- Administrative Law and FDA Litigation
- Agribusiness
- Antitrust + Competition
- Appellate and Supreme Court Litigation
- Artificial Intelligence + Machine Learning
B
C
- Cannabis
- Capital Markets
- China
- Class Actions
- CleanTech
- Complex Litigation + Dispute Resolution
- Consumer Financial Services
- Consumer Financial Services Enforcement + Government Investigations
- Consumer Financial Services Litigation
- Copyrights
- Corporate Social Responsibility Law + Policy
- Crowdfunding
D
- Debt Capital Markets
- Debt Finance
- Derivatives
- Digital Currency + Blockchain Technology
- Direct Listings
- Distressed Real Estate
E
F
- Fair + Responsible Lending
- False Claims Act
- FDA
- Financial Industry
- Financial Industry Advisory Services
- Financial Industry Litigation
- Financial Industry Litigation Services
- Financial Industry Transactional Services
- Financial Restructuring
- Fintech
- Food + Healthy Living
- Foreign Corrupt Practices Act
G
- Gaming + Gambling
- Global Trade
- Government Contracts + Disputes
- Government Investigations + Enforcement
- Growth Equity
H
- Hatch-Waxman, Biologics and Biosimilars Litigation
- Healthcare
- Healthcare Investigations
- Healthcare IT, Tech + Digital Health
- Healthcare Litigation
- Healthcare Regulatory
- Healthcare Services
- Hedge Funds
- Higher Education
- Hospitality + Leisure
I
- Impact + Responsible Investing
- India
- Insurance
- Intellectual Property
- Investment Management
- Investment Management Litigation
- Israel
- ITC 337 Proceedings
L
- Late Stage Drug Development
- Leasing
- Life Sciences
- Life Sciences Asia
- Life Sciences Collaborations + Licensing
- Life Sciences Emerging Companies
- Life Sciences Europe
- Life Sciences IPOs + Capital Markets
- Life Sciences M + A
- Life Sciences Patent Prosecution + Counseling
- Life Sciences Securities Litigation + Healthcare Fraud
M
N
O
P
- Patent Litigation
- Patent Prosecution + Counseling
- Patent Trial + Appeal Board
- Pharmaceuticals
- Privacy + Cybersecurity
- Private Equity
- Private Equity Asia
- Private Equity France
- Private Equity Germany
- Private Equity UK
- Private Equity US East Coast
- Private Equity US West Coast
- Private Investment Funds
- Products Litigation and Counseling
- Proposition 65 + Food Labeling Litigation
- Propsci
- Proptech
- Public Companies
R
- Real Estate Acquisitions + Dispositions
- Real Estate Design + Construction
- Real Estate Development + Permitting
- Real Estate Dispute Resolution
- Real Estate Finance + Restructurings
- Real Estate Industry
- Real Estate Investment Funds
- Real Estate Joint Ventures
- Real Estate Tax
- REITs and Real Estate M+A
- Risk Management + Insurance
S
- Search Funds
- Secondaries
- Securities + Shareholder Litigation
- Shareholder Activism
- Special Purpose Acquisition Companies (SPACs)
- Strategic Technology Transactions and Licensing
T
- Tax
- Tax-Exempt Organizations
- Technology
- Technology Europe
- Trade Secrets + Restrictive Covenants
- Trademarks
- Transportation
- Trusts + Estates Court Practice
- Trusts + Estates Planning
- Trusts + Estates Planning Advisory Services
U
V
W